Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arghavan Almony

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Retina (Philadelphia, Pa.)|January 25, 2013
Reply: To PMID 22105502Arghavan Almony, Eric Nudleman, Gaurav K Shah, et al.
American Journal of Ophthalmology|January 7, 2014
Clinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degenerationNancy M Holekamp, Ying Liu, Wei-Shi Yeh, et al.
American Journal of Ophthalmology|April 24, 2018
Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical PracticeNancy M Holekamp, Joanna Campbell, Arghavan Almony, et al.
Retina (Philadelphia, Pa.)|November 23, 2011
Techniques, rationale, and outcomes of internal limiting membrane peelingArghavan Almony, Eric Nudleman, Gaurav K Shah, et al.
Journal of Managed Care & Specialty Pharmacy|August 31, 2021
Clinical and economic burden of neovascular age-related macular degeneration by disease status: a US claims-based analysisArghavan Almony, Katelyn R Keyloun, Bijal Shah-Manek, et al.
Retinal Cases & Brief Reports|November 13, 2014
Histologic and immunohistochemical features of an epiretinal membrane overlying a combined hamartoma of the retina and retinal pigment epitheliumArghavan Almony, Kevin J Blinder, George J Harocopos, et al.
Ophthalmology|July 30, 2013
Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathyMichael A Grassi, Wanjie Sun, Sapna Gangaputra, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Retina (Philadelphia, Pa.)|January 25, 2013
Reply: To PMID 22105502Arghavan Almony, Eric Nudleman, Gaurav K Shah, et al.
American Journal of Ophthalmology|January 7, 2014
Clinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degenerationNancy M Holekamp, Ying Liu, Wei-Shi Yeh, et al.
American Journal of Ophthalmology|April 24, 2018
Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical PracticeNancy M Holekamp, Joanna Campbell, Arghavan Almony, et al.
Retina (Philadelphia, Pa.)|November 23, 2011
Techniques, rationale, and outcomes of internal limiting membrane peelingArghavan Almony, Eric Nudleman, Gaurav K Shah, et al.
Journal of Managed Care & Specialty Pharmacy|August 31, 2021
Clinical and economic burden of neovascular age-related macular degeneration by disease status: a US claims-based analysisArghavan Almony, Katelyn R Keyloun, Bijal Shah-Manek, et al.
Retinal Cases & Brief Reports|November 13, 2014
Histologic and immunohistochemical features of an epiretinal membrane overlying a combined hamartoma of the retina and retinal pigment epitheliumArghavan Almony, Kevin J Blinder, George J Harocopos, et al.
Ophthalmology|July 30, 2013
Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathyMichael A Grassi, Wanjie Sun, Sapna Gangaputra, et al.
Pageof 3